Detalhe da pesquisa
1.
CXCR2 inhibition suppresses acute and chronic pancreatic inflammation.
J Pathol
; 237(1): 85-97, 2015 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-25950520
2.
A phase I, open-label, randomized crossover study to assess the effect of dosing of the MEK 1/2 inhibitor Selumetinib (AZD6244; ARRY-142866) in the presence and absence of food in patients with advanced solid tumors.
Cancer Chemother Pharmacol
; 68(6): 1619-28, 2011 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-21953275
3.
Telomerase and cancer: time to move from a promising target to a clinical reality.
J Pathol
; 195(4): 404-14, 2001 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-11745671